FR Doc E8-18045[Federal Register: August 6, 2008 (Volume 73,
Number 152)] [Notices] [Page 45780-45781] From the Federal
Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06au08-85]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall,
prior to issuing a registration under this section to a bulk
manufacturer of a controlled substance in schedule I or II, and
prior to issuing a regulation under 21
U.S.C. 952(a)(2)
authorizing the importation of such a substance, provide
manufacturers holding registrations for the bulk manufacture of
the substance an opportunity for a hearing.
Therefore, in accordance with Title 21 Code of Federal
Regulations (CFR), 1301.34(a), this is notice that on March 26,
2008, BA Research International LLC, 10550 Rockley Road, Suite
150, Houston, Texas 77099- 0000, made application to the Drug
Enforcement Administration (DEA) to be registered as an importer
of the basic classes of controlled substances listed in
schedules I and II:
Drug
|
Schedule
|
4-Methylaminorex (cis isomer) (1590)
|
I
|
Gamma Hydroxybutyric Acid (2010)
|
I
|
Methaqualone (2565)
|
I
|
Ibogaine (7260)
|
I
|
Lysergic acid diethylamide (7315)
|
I
|
Marihuana (7360)
|
I
|
Tetrahydrocannabinols (7370)
|
I
|
Cannabidiol (7372)
|
I
|
Mescaline (7381)
|
I
|
4-Methyl-2,5-dimethoxyamphet- amine (7395)
|
I
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
3,4-Methylenedioxymethamphet- amine (7405)
|
I
|
Peyote (7415)
|
I
|
Bufotenine (7433)
|
I
|
Diethyltryptamine (7434)
|
I
|
Dimethyltryptamine (7435)
|
I
|
Psilocybin (7437)
|
I
|
Etorphine (except HCL) (9056)
|
I
|
Heroin (9200)
|
I
|
Normorphine (9313)
|
I
|
Alphacetylmethadol except levo-alphacetylmethadol (9603)
|
I
|
Amphetamine (1100)
|
II
|
Methamphetamine (1105)
|
II
|
Methylphenidate (1724)
|
II
|
Amobarbital (2125)
|
II
|
Pentobarbital (2270)
|
II
|
Secobarbital (2315)
|
II
|
Phencyclidine (7471)
|
II
|
Cocaine (9041)
|
II
|
Codeine (9050)
|
II
|
Diprenorphine (9058)
|
II
|
Etorphine HCL (9059)
|
II
|
Oxycodone (9143)
|
II
|
Hydromorphone (9150)
|
II
|
Diphenoxylate (9170)
|
II
|
Ethylmorphine (9190)
|
II
|
Levorphanol (9220)
|
II
|
Dextropropoxyphene, bulk (non-dosage forms) (9273)
|
II
|
Thebaine (9333)
|
II
|
Opium, raw (9600)
|
II
|
Opium, powdered (9639)
|
II
|
Levo-alphacetylmethadol (9648)
|
II
|
Oxymorphone (9652)
|
II
|
Fentanyl (9801)
|
II
|
Hydrocodone (9193)
|
II
|
Meperidine (9230)
|
II
|
Methadone (9250)
|
II
|
Morphine (9300)
|
II
|
The company plans to import analytical reference standards
for analytical testing of blood samples from clinical trials.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of
controlled substances may file comments or objections to the
issuance of the proposed registration and may, at the same time,
file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by
21
CFR 1316.47.
Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive,
[[Page 45781]]
Springfield, Virginia 22152; and must be filed no later than
September 5, 2008.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR
1301.34(b),
(c), (d), (e), and (f). As noted in a previous notice published
in the Federal Register on September 23, 1975, (40 FR 43745),
all applicants for registration to import a basic class of any
controlled substance in schedule I or II are, and will continue
to be, required to demonstrate to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, that the requirements for such registration
pursuant to 21
U.S.C. 958(a); 21
U.S.C. 823(a); and 21 CFR
1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: July 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E8-18045 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).